01.01.06
Indication: Sick-leave
Source: Environmental Health: A Global Access Science Source, November 2005;4:25.
Research: This study examined the effect of the probiotic Lactobacillus reuteri protectis (ATCC55730) on its ability to improve work-place healthiness by reducing short-term sick-leave caused by respiratory or gastrointestinal infections. Just over 260 employees at TetraPak in Sweden (day workers and three-shift workers) that were healthy at study start were randomized in a double-blind fashion to receive either a daily dose of 108 colony forming units of L. reuteri or placebo for 80 days. The study products were administered with a drinking straw. One hundred and eighty-one subjects complied with the study protocol, 94 were randomized to receive L. reuteri and 87 received placebo.
Results: In the placebo group, 26% reported sick-leave for the defined causes during the study as compared with 11% in the L. reuteri group. The frequency of sick days was nearly 1% in the placebo group and 0.4% in the L. reuteri group. Among the 53 shift-workers, 33% in the placebo group reported sick-leave during the study period as compared with none in the L. reuteri group.
Source: Environmental Health: A Global Access Science Source, November 2005;4:25.
Research: This study examined the effect of the probiotic Lactobacillus reuteri protectis (ATCC55730) on its ability to improve work-place healthiness by reducing short-term sick-leave caused by respiratory or gastrointestinal infections. Just over 260 employees at TetraPak in Sweden (day workers and three-shift workers) that were healthy at study start were randomized in a double-blind fashion to receive either a daily dose of 108 colony forming units of L. reuteri or placebo for 80 days. The study products were administered with a drinking straw. One hundred and eighty-one subjects complied with the study protocol, 94 were randomized to receive L. reuteri and 87 received placebo.
Results: In the placebo group, 26% reported sick-leave for the defined causes during the study as compared with 11% in the L. reuteri group. The frequency of sick days was nearly 1% in the placebo group and 0.4% in the L. reuteri group. Among the 53 shift-workers, 33% in the placebo group reported sick-leave during the study period as compared with none in the L. reuteri group.